Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed with results

Key Signals

4 with results75% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (8)

Trial Status

Completed6
Terminated2
Enrolling By Invitation1
Active Not Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (10)

Research Network

Activity Timeline